Literature DB >> 11318763

Methods to identify drug deposition in the lungs following inhalation.

H Chrystyn1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11318763      PMCID： PMC2014454          DOI： 10.1046/j.1365-2125.2001.01304.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  74 in total

1.  The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography.

Authors:  Q A Summers; J S Fleming; Y Dai; S Perring; R Honeywell; K J Gough; A G Renwick; A R Clark; M A Nassim; S T Holgate
Journal:  J Aerosol Med       Date:  1996-03

2.  Lung bioavailability of generic and innovator salbutamol MDIs.

Authors:  H Chrystyn; S A Corlett; V Silkstone
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

3.  Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.

Authors:  D J Clark; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1996-03       Impact factor: 4.335

4.  Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.

Authors:  H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1996-08       Impact factor: 4.335

5.  Lung bioavailability of generic and innovator salbutamol metered dose inhalers.

Authors:  D J Clark; J Gordon-Smith; G McPhate; G Clark; B J Lipworth
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

6.  Evaluation of plasma and urinary salbutamol levels in COPD.

Authors:  D J Clark; K S Tan; B J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 7.  Beta-adrenergic receptors and their regulation.

Authors:  P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

8.  Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration.

Authors:  H Derendorf; G Hochhaus; S Rohatagi; H Möllmann; J Barth; H Sourgens; M Erdmann
Journal:  J Clin Pharmacol       Date:  1995-03       Impact factor: 3.126

9.  The inhalation device influences lung deposition and bronchodilating effect of terbutaline.

Authors:  L Borgström; E Derom; E Ståhl; E Wåhlin-Boll; R Pauwels
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

10.  Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.

Authors:  S J Farr; A M Rowe; R Rubsamen; G Taylor
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139
View more
  18 in total

1.  Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation.

Authors:  H S Tomlinson; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

2.  Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.

Authors:  Heather S Tomlinson; Sarah A Corlett; Martin B Allen; Henry Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

Review 3.  Deposition and effects of inhaled corticosteroids.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.

Authors:  Maryam Khoubnasabjafari; Elaheh Rahimpour; Morteza Samini; Vahid Jouyban-Gharamaleki; Lan Chen; Donghao Chen; Hak-Kim Chan; Abolghasem Jouyban
Journal:  Daru       Date:  2019-03-07       Impact factor: 3.117

5.  Determination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers.

Authors:  A I Al-Amoud; B J Clark; K A Assi; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

6.  Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler.

Authors:  Jason Perry; Brian Trautman; Joe Takher-Smith; Steve Kramer; Katie Kane; Michael Silverman; Lisa Tan; Scott Haughie; Wolfram Richter; Valentin Kirkov; Sacha Arsova; Jonathan Ward; David L Hava
Journal:  Br J Clin Pharmacol       Date:  2019-01-15       Impact factor: 4.335

Review 7.  Closer to an 'ideal inhaler' with the Easyhaler: an innovative dry powder inhaler.

Authors:  Henry Chrystyn
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 8.  Spacer devices for metered dose inhalers.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination.

Authors:  Jean Bousquet; Gianluigi Poli; Daniela Acerbi; Raffaella Monno; Steven Ramael; Fabrice Nollevaux
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.

Authors:  Wilfried De Backer; Annick Devolder; Gianluigi Poli; Daniela Acerbi; Raffaella Monno; Christiane Herpich; Knut Sommerer; Thomas Meyer; Fabrizia Mariotti
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-06       Impact factor: 2.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.